Slide Library

Integrating Obesity Medicine into Your Practice

Do you want to incorporate obesity medicine into your medical practice but don't know where to start? The disease of obesity is increasing at an alarming rate in the US and worldwide.

READ MORE

Obesity: Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)

Key Points Key Points

  • Define NAFLD and NASH
  • Screening and diagnosis of NAFLD and NASH
  • Progression and presentation of NASH

READ MORE

Individualizing Weight Loss Therapy

Help your patients understand Obesity is a disease and it needs to be treated. Obesity is quickly becoming an epidemic in the United States.

READ MORE

Clinical Benefits of Weight Loss

Key Points
  • Obesity is a chronic relapsing progressive disease defined by abnormal or excessive adiposity that may impair health.
  • Improved ability to engage in activities of daily living such as improved mo

READ MORE

Obesity Pathophysiology

Key Points
  • Obesity has a genetic basis as well as environmental and behavioral origins
  • Age contributes to a shift in balance between fat and muscle mass
  • Various negative feedback loops contribu

READ MORE

2.5 Psychological Complications (Coming Soon)

Key Points
  • Depression, anxiety, eating disorders, and other psychological conditions frequently are associated with obesity
  • Weight loss may positively affect the psychological complications of obesity.

READ MORE

3.1 Lifestyle Intervention

Key Points
  • Lifestyle interventions effectively prevent physical and metabolic complications of obesity
    • Lifestyle alone is less effective in populations with more severe obesity

READ MORE

3.2 When to Initiate Pharmacotherapy

Key Points
  • Weight-loss medications should be considered when obesity-related complications can be ameliorated by weight loss.
  • Pharmacotherapy should always be combined with lifestyle therapy, never used

READ MORE

3.3 Weight Loss Medications

Key Points
  • Older obesity pharmacotherapies are limited by tolerability and dependence issues and are approved only for short-term use (≤12 weeks).
  • Newer weight loss agents are typically better tolerated,

READ MORE

3.4 Bariatric Surgery

Key Points
  • Four weight-loss surgical options are available
    • Laparoscopic adjustable gastric band (LAGB)
    • Laparscopic sleeve gastrectomy (LSG)
    • Biliopancreatic diversion with or witho

READ MORE

Anthropometric Evaluation

Key Points
  • Evaluation of patients for obesity should include a complete history and physical examination
  • Body mass index (BMI) cutpoints vary with race and ethnicity
  • Waist circumference

READ MORE

1.4 Clinical Evaluation

Key Points
  • Clinical evaluation of obese patients should include a complete history and physical examination
  • Comorbidities and obesity complications should also be assessed
  • Treatment plans shoul

READ MORE

2.1 Epidemiology

Key Points
  • Obesity is increasing globally
    • Rates of obesity have risen dramatically in the U.S.

READ MORE

2.2 Metabolic Complications

Key Points
  • Obesity is associated with higher risks of prediabetes and type 2 diabetes (T2D)
  • Weight loss with lifestyle therapy, pharmacotherapy, or bariatric surgery
    • Reduces the risk of progr

READ MORE

2.3 Cardiovascular Complications

Key Points
  • Obesity is associated with increased cardiovascular risk
  • Weight loss by means of lifestyle therapy, pharmacotherapy, or bariatric surgery positively affects cardiovascular risk markers

READ MORE

2.4 Organ-Specific, Hormonal, and Biomechanical Complications

Key Points
  • Numerous organ-specific and biomechanical complications accompany obesity
  • Weight loss ameliorates all of these conditions

READ MORE